Barclays’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $771K | Buy |
112,063
+29,606
| +36% | +$204K | ﹤0.01% | 2813 |
|
|
2025
Q1 | $238K | Sell |
82,457
-39,613
| -32% | -$114K | ﹤0.01% | 3235 |
|
|
2024
Q4 | $575K | Sell |
122,070
-2,071
| -2% | -$9.76K | ﹤0.01% | 2971 |
|
|
2024
Q3 | $443K | Buy |
124,141
+97,565
| +367% | +$348K | ﹤0.01% | 3065 |
|
|
2024
Q2 | $165K | Sell |
26,576
-44,939
| -63% | -$279K | ﹤0.01% | 3146 |
|
|
2024
Q1 | $675K | Buy |
71,515
+3,330
| +5% | +$31.4K | ﹤0.01% | 2663 |
|
|
2023
Q4 | $460K | Buy |
+68,185
| New | +$460K | ﹤0.01% | 3044 |
|
|
2023
Q3 | – | Sell |
-144,983
| Closed | -$478K | – | 4295 |
|
|
2023
Q2 | $478K | Buy |
144,983
+117,730
| +432% | +$388K | ﹤0.01% | 2623 |
|
|
2023
Q1 | $77K | Buy |
27,253
+15,561
| +133% | +$44K | ﹤0.01% | 3648 |
|
|
2022
Q4 | $85K | Buy |
11,692
+10,244
| +707% | +$74.5K | ﹤0.01% | 3554 |
|
|
2022
Q3 | $12K | Sell |
1,448
-265
| -15% | -$2.2K | ﹤0.01% | 4104 |
|
|
2022
Q2 | $8K | Sell |
1,713
-21,667
| -93% | -$101K | ﹤0.01% | 4377 |
|
|
2022
Q1 | $553K | Buy |
+23,380
| New | +$553K | ﹤0.01% | 2739 |
|